Morgan Stanley Maintains Equal-Weight on DexCom, Raises Price Target to $101
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Patrick Wood has maintained an Equal-Weight rating on DexCom (NASDAQ:DXCM) and raised the price target from $98 to $101.
October 27, 2023 | 1:07 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Morgan Stanley has maintained an Equal-Weight rating on DexCom and raised the price target from $98 to $101.
The news is directly related to DexCom and is likely to have a positive impact on its stock price in the short term. The increase in the price target by Morgan Stanley indicates a positive outlook for the company.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100